Clinical trial
The Application of Molecular Probe Targeting Fibroblast Activation Protein in Malignant Tumor of Digestive System
NCT05420558 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Application of Molecular Probe Targeting Fibroblast Activation Protein in Malignant Tumor of Digestive System
- Lead sponsor
- Zhongnan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 23, 2022
- Completion date
- December 31, 2023
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal cancer